- Sensors
- Genetically encoded calcium indicators
- pH sensors
- Chloride sensors
- Neurotransmitter release sensors
- Voltage-sensitive fluorescent proteins
- Actuators
- Halorhodopsin
- Archaerhodopsin
- Channelrhodopsin
- Others
- Light Equipment
- LEDs
- Laser
- Others
Optogenetics Market size was valued at USD 521.6 million in 2022, and is expected to reach USD 652.21 million by 2028, growing at a significant CAGR of 3.9% from 2023-2029. Optogenetics is the biological technique in neuroscience used for controlling the cells in the living tissue with the help of a light. Optogenetics is majorly used for monitor and control the activities of neurons in living tissue. Light-sensitive proteins are used as key reagents in the optogenetics. The neuronal control achieved by using optogenetic actuators such as halorhodopsin, channelrhodopsin, and archaerhodopsin. Optical recording of the neuronal activities made with optogenetic sensors for the neurotransmitter, membrane voltage, vesicular release, or calcium. Optogenetics is adopted in the ophthalmology, cardiology, behavioural science, neuroscience, and others. Increase in the adoption of optogenetics in the behavioural and neuroscience, technological advancements in optogenetics, growth in ultrafast laser tool technology are the key factors driving the growth of the market. Moreover, rise in the number of research laboratories adopting optogenetics technology around the globe and development in the genetic engineering research expected to propel the optogenetics market over the forecast period. However, a high cost of the technology, lack of awareness about the optogenetics, and the dearth of skilled professionals for optogenetic research might hamper the market over the forecast period.
Global Optogenetics Market Summary
Study Period
2023-29
Base Year
2022
CAGR
3.9%
Largest Market
North America
Fastest Growing Market
Europe
Optogenetics Market Dynamics
Global optogenetics market is growing at a significant CAGR owing to rise in the adoption of optogenetics technology in neuroscience and behavioural science. An innovation of newer technologies for various diseases such as obesity and retinal diseases on optogenetics platform might fuel the market growth in near future. For instance, in August 2015, Boehringer Ingelheim and Circuit therapeutic have collaborated to develop the novel medicines for obesity on optogenetics technology platform. Acquisitions and mergers, collaborations, technological advancements, and fundraising are the strategies adopted by the companies for increasing their revenue in optogenetics market. For instance, in November 2015, RetroSense Therapeutics secured US$ 6Mn Series B financing from various organizations for the clinical development of RST-001 for the treatment of Retinitis pigmentosa. Moreover, in November 2016, Bruker targeted on optogenetics market by commercializing NeuraLight 3D an optical module for stimulating and imaging the multiple neurons.
North-America Got Significant Share
Optogenetics Market Regional Analysis
Geographically, optogenetics market is segmented into North America, Latin America, Asia Pacific, Europe, and Middle East & Africa. Increase in the R&D activities in neuroscience and optogenetics and availability of professional researchers in North America is anticipated to create demand for optogenetics research in the region. Moreover, the market is developing in the Europe region owing to collaboration between the companies for developing newer technologies on optogenetics platform. However, technological developments in market, increase in the applications of optogenetics, and rise in R&D activities in Asia Pacific region plays a key role in optogenetics market growth.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The optogenetics market report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Global Optogenetics Market Segmentation
By Product Type
By Technique
- Viral Vectors
- Transgenic Animals
- Cre-Dependant Expression System
By Application
- Neuroscience
- Behavioural science
- Cardiovascular diseases
- Retinal disease treatment
- Others
By End-User
- Pharmaceutical & Biopharmaceutical companies
- Biotechnology companies
- Academic research institutes
By Geography
- North America
- Europe
- Asia Pacific
- Latin America
- MEA
Frequently Asked Questions
The Optogenetics market size was valued at USD 521.6 million in 2022.
The key segments covered in the optogenetics market are technology, components, application, and end-users.
The Optogenetics market key players are Coherent, Inc. (U.S.), Noldus Information technology (Netherlands), Thorlabs, Inc. (U.S.), Bruker (U.S.), Laserglow Technologies (Canada), Regenexbio, Inc. (U.S.), GenSight Biologics S.A. (France), Jackson Laboratory (U.S.), Applied Genetic Technologies Corporation (U.S.), Circuit Therapeutics, Inc. (U.S.)
| 1.Executive Summary |
| 2.Global Optogenetics Market Introduction |
| 2.1.Global Optogenetics Market - Taxonomy |
| 2.2.Global Optogenetics Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.Technique |
| 2.2.3.Application |
| 2.2.4.End-User |
| 2.2.5.Region |
| 3.Global Optogenetics Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Optogenetics Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
| 4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Optogenetics Market By Product Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 5.1. Sensors |
| 5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Actuators |
| 5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Light Equipment |
| 5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6.Global Optogenetics Market By Technique, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 6.1. Viral Vectors |
| 6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Transgenic Animals |
| 6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Cre-Dependant Expression System |
| 6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7.Global Optogenetics Market By Application, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 7.1. Neuroscience |
| 7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Behavioural science |
| 7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Cardiovascular diseases |
| 7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Retinal disease treatment |
| 7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Others |
| 7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8.Global Optogenetics Market By End-User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 8.1. Pharmaceutical & Biopharmaceutical companies |
| 8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Biotechnology companies |
| 8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Academic research institutes |
| 8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 9.Global Optogenetics Market By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia Pacific (APAC) |
| 9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Middle East and Africa (MEA) |
| 9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Latin America |
| 9.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 10.North America Optogenetics Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 10.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Sensors |
| 10.1.2.Actuators |
| 10.1.3.Light Equipment |
| 10.2. Technique Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Viral Vectors |
| 10.2.2.Transgenic Animals |
| 10.2.3.Cre-Dependant Expression System |
| 10.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Neuroscience |
| 10.3.2.Behavioural science |
| 10.3.3.Cardiovascular diseases |
| 10.3.4.Retinal disease treatment |
| 10.3.5.Others |
| 10.4. End-User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Pharmaceutical & Biopharmaceutical companies |
| 10.4.2.Biotechnology companies |
| 10.4.3.Academic research institutes |
| 10.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.5.1.United States of America (USA) |
| 10.5.2.Canada |
| 11.Europe Optogenetics Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Sensors |
| 11.1.2.Actuators |
| 11.1.3.Light Equipment |
| 11.2. Technique Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Viral Vectors |
| 11.2.2.Transgenic Animals |
| 11.2.3.Cre-Dependant Expression System |
| 11.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Neuroscience |
| 11.3.2.Behavioural science |
| 11.3.3.Cardiovascular diseases |
| 11.3.4.Retinal disease treatment |
| 11.3.5.Others |
| 11.4. End-User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Pharmaceutical & Biopharmaceutical companies |
| 11.4.2.Biotechnology companies |
| 11.4.3.Academic research institutes |
| 11.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.5.1.Germany |
| 11.5.2.France |
| 11.5.3.Italy |
| 11.5.4.United Kingdom (UK) |
| 11.5.5.Spain |
| 11.5.6.Rest of EU |
| 12.Asia Pacific (APAC) Optogenetics Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Sensors |
| 12.1.2.Actuators |
| 12.1.3.Light Equipment |
| 12.2. Technique Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Viral Vectors |
| 12.2.2.Transgenic Animals |
| 12.2.3.Cre-Dependant Expression System |
| 12.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Neuroscience |
| 12.3.2.Behavioural science |
| 12.3.3.Cardiovascular diseases |
| 12.3.4.Retinal disease treatment |
| 12.3.5.Others |
| 12.4. End-User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Pharmaceutical & Biopharmaceutical companies |
| 12.4.2.Biotechnology companies |
| 12.4.3.Academic research institutes |
| 12.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.5.1.China |
| 12.5.2.India |
| 12.5.3.Australia and New Zealand (ANZ) |
| 12.5.4.Japan |
| 12.5.5.Rest of APAC |
| 13.Middle East and Africa (MEA) Optogenetics Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Sensors |
| 13.1.2.Actuators |
| 13.1.3.Light Equipment |
| 13.2. Technique Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Viral Vectors |
| 13.2.2.Transgenic Animals |
| 13.2.3.Cre-Dependant Expression System |
| 13.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Neuroscience |
| 13.3.2.Behavioural science |
| 13.3.3.Cardiovascular diseases |
| 13.3.4.Retinal disease treatment |
| 13.3.5.Others |
| 13.4. End-User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Pharmaceutical & Biopharmaceutical companies |
| 13.4.2.Biotechnology companies |
| 13.4.3.Academic research institutes |
| 13.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.5.1.GCC Countries |
| 13.5.2.South Africa |
| 13.5.3.Rest of MEA |
| 14.Latin America Optogenetics Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 14.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.Sensors |
| 14.1.2.Actuators |
| 14.1.3.Light Equipment |
| 14.2. Technique Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Viral Vectors |
| 14.2.2.Transgenic Animals |
| 14.2.3.Cre-Dependant Expression System |
| 14.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Neuroscience |
| 14.3.2.Behavioural science |
| 14.3.3.Cardiovascular diseases |
| 14.3.4.Retinal disease treatment |
| 14.3.5.Others |
| 14.4. End-User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Pharmaceutical & Biopharmaceutical companies |
| 14.4.2.Biotechnology companies |
| 14.4.3.Academic research institutes |
| 14.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.5.1.Brazil |
| 14.5.2.Mexico |
| 14.5.3.Rest of LA |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.Coherent, Inc. (U.S) |
| 15.2.2.Noldus Information technology (Netherlands) |
| 15.2.3.Thorlabs, Inc. (U.S) |
| 15.2.4.Bruker (U.S) |
| 15.2.5.Laserglow Technologies (Canada) |
| 15.2.6.Regenexbio, Inc. (U.S) |
| 15.2.7.GenSight Biologics S.A. (France) |
| 15.2.8.Jackson Laboratory (U.S) |
| 15.2.9.Applied Genetic Technologies Corporation (U.S) |
| 15.2.10.Circuit Therapeutics, Inc. (U.S) |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
- Coherent, Inc. (U.S)
- Noldus Information technology (Netherlands)
- Thorlabs, Inc. (U.S)
- Bruker (U.S)
- Laserglow Technologies (Canada)
- Regenexbio, Inc. (U.S)
- GenSight Biologics S.A. (France)
- Jackson Laboratory (U.S)
- Applied Genetic Technologies Corporation (U.S)
- Circuit Therapeutics, Inc. (U.S)